Royal Bank of Canada’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
120
| – | – | ﹤0.01% | 6885 |
|
|
2025
Q1 | $0 | Hold |
120
| – | – | ﹤0.01% | 6684 |
|
|
2024
Q4 | $0 | Hold |
120
| – | – | ﹤0.01% | 6655 |
|
|
2024
Q3 | $0 | Sell |
120
-271
| -69% | – | ﹤0.01% | 6931 |
|
|
2024
Q2 | $0 | Buy |
391
+250
| +177% | – | ﹤0.01% | 7036 |
|
|
2024
Q1 | $0 | Sell |
141
-320
| -69% | – | ﹤0.01% | 6983 |
|
|
2023
Q4 | $1K | Sell |
461
-1,453
| -76% | -$3.15K | ﹤0.01% | 6445 |
|
|
2023
Q3 | $4K | Buy |
1,914
+1,794
| +1,495% | +$3.75K | ﹤0.01% | 6180 |
|
|
2023
Q2 | $0 | Sell |
120
-128
| -52% | – | ﹤0.01% | 7115 |
|
|
2023
Q1 | $0 | Sell |
248
-210
| -46% | – | ﹤0.01% | 6948 |
|
|
2022
Q4 | $1K | Buy |
458
+292
| +176% | +$638 | ﹤0.01% | 6610 |
|
|
2022
Q3 | $0 | Buy |
166
+27
| +19% | – | ﹤0.01% | 7296 |
|
|
2022
Q2 | $1K | Sell |
139
-1,095
| -89% | -$7.88K | ﹤0.01% | 6745 |
|
|
2022
Q1 | $13K | Buy |
1,234
+1,100
| +821% | +$11.6K | ﹤0.01% | 6357 |
|
|
2021
Q4 | $2K | Sell |
134
-106
| -44% | -$1.58K | ﹤0.01% | 6890 |
|
|
2021
Q3 | $7K | Sell |
240
-654
| -73% | -$19.1K | ﹤0.01% | 6540 |
|
|
2021
Q2 | $42K | Buy |
894
+238
| +36% | +$11.2K | ﹤0.01% | 5658 |
|
|
2021
Q1 | $39K | Buy |
656
+87
| +15% | +$5.17K | ﹤0.01% | 5545 |
|
|
2020
Q4 | $30K | Buy |
569
+345
| +154% | +$18.2K | ﹤0.01% | 5333 |
|
|
2020
Q3 | $8K | Sell |
224
-145
| -39% | -$5.18K | ﹤0.01% | 5521 |
|
|
2020
Q2 | $32K | Buy |
369
+128
| +53% | +$11.1K | ﹤0.01% | 4935 |
|
|
2020
Q1 | $15K | Sell |
241
-60
| -20% | -$3.73K | ﹤0.01% | 5180 |
|
|
2019
Q4 | $22K | Buy |
301
+101
| +51% | +$7.38K | ﹤0.01% | 5220 |
|
|
2019
Q3 | $12K | Hold |
200
| – | – | ﹤0.01% | 5098 |
|
|
2019
Q2 | $19K | Buy |
200
+120
| +150% | +$11.4K | ﹤0.01% | 4981 |
|
|
2019
Q1 | $6K | Hold |
80
| – | – | ﹤0.01% | 5278 |
|
|
2018
Q4 | $13K | Sell |
80
-20
| -20% | -$3.25K | ﹤0.01% | 5014 |
|
|
2018
Q3 | $16K | Buy |
100
+18
| +22% | +$2.88K | ﹤0.01% | 5178 |
|
|
2018
Q2 | $12K | Buy |
+82
| New | +$12K | ﹤0.01% | 5186 |
|